Centro de Investigação de Patobiologia Molecular, Instituto Português de Oncologia de Lisboa Francisco Gentil E.P.E., 1099-023 Lisboa, Portugal.
J Oncol. 2012;2012:359246. doi: 10.1155/2012/359246. Epub 2012 Mar 11.
Two common variants, close from TTF-1 and TTF-2, were shown to predispose to thyroid cancer (TC) in European populations. We aimed to investigate whether TTF-1 and TTF-2 variants might contribute to TC early onset (EO). Tumor samples from eighteen patients with papillary TC (PTC), who underwent total thyroidectomy at an age of ≤21, were screened for TTF-1 and TTF-2 variants. No TTF-1 variants were documented; two novel germinal TTF-2 variants, c.200C>G (p.A67G) and c.510C>A (p.A170A), were identified in two patients. Two already described TTF-2 variants were also documented; the allelic frequency among patients was not different from that observed among controls. Moreover, RET/PTC rearrangements and the BRAFV600E mutation were identified in 5/18 and 2/18 PTCs, respectively. Thyroglobulin (TG) and thyroid peroxidase (TPO) expression was found to be significantly decreased in tumors, and the lowest level of TPO expression occurred in a tumor harboring both the p.A67GTTF-2 variant and a RET/PTC3 rearrangement.
两种常见的变体,靠近 TTF-1 和 TTF-2,被证明易患甲状腺癌 (TC) 在欧洲人群中。我们旨在研究 TTF-1 和 TTF-2 变体是否可能导致甲状腺癌早期发病 (EO)。对 18 例年龄≤21 岁接受全甲状腺切除术的乳头状甲状腺癌 (PTC) 患者的肿瘤样本进行了 TTF-1 和 TTF-2 变体的筛查。未发现 TTF-1 变体;在两名患者中鉴定出两种新的生殖系 TTF-2 变体,c.200C>G (p.A67G) 和 c.510C>A (p.A170A)。还记录了两种已经描述的 TTF-2 变体;患者中的等位基因频率与对照组观察到的无差异。此外,在 5/18 和 2/18 的 PTC 中分别鉴定出 RET/PTC 重排和 BRAFV600E 突变。发现肿瘤中甲状腺球蛋白 (TG) 和甲状腺过氧化物酶 (TPO) 的表达显著降低,并且在同时携带 p.A67GTTF-2 变体和 RET/PTC3 重排的肿瘤中 TPO 表达水平最低。